Cognition Therapeutics downgraded by Cantor Fitzgerald
$CGTX
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Cantor Fitzgerald downgraded Cognition Therapeutics from Overweight to Neutral
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
12/19/2024 | $1.00 → $1.50 | Neutral → Buy | B. Riley Securities |
7/30/2024 | Overweight → Neutral | Cantor Fitzgerald | |
11/3/2021 | $27.00 | Buy | B. Riley Securities |
11/3/2021 | $22.00 | Outperform | Oppenheimer |
8-K - COGNITION THERAPEUTICS INC (0001455365) (Filer)
8-K - COGNITION THERAPEUTICS INC (0001455365) (Filer)
8-K - COGNITION THERAPEUTICS INC (0001455365) (Filer)
4 - COGNITION THERAPEUTICS INC (0001455365) (Issuer)
4 - COGNITION THERAPEUTICS INC (0001455365) (Issuer)